Is ICH exportable outside the European Union?

Area of Science:

• Clinical Research Standards
• International Regulatory Compliance

Background:

• The International Conference on Harmonisation (ICH) Good Clinical Practices (GCP) Guidelines are globally recognized.
• Major regulatory bodies like the USA, Japan, and Europe have integrated ICH GCPs into their national legislation.

Purpose of the Study:

• To assess the exportability and practical application of ICH GCP Guidelines outside the European Union (EU).
• To determine if clinical trials conducted outside Western Europe can achieve the same or higher standards of quality.

Main Methods:

• Evaluation based on a 16-center clinical study for nonseasonal rhinitis in the Czech Republic and Poland.
• Inclusion of audit findings and comparison with other therapeutic areas and studies in non-EU countries.
• Case study highlighting a head and neck cancer trial in India involving photodynamic therapy.

Main Results:

• The clinical study in the Czech Republic and Poland demonstrated a very high standard of compliance with ICH GCPs.
• Evidence from multiple studies indicates that clinical trial standards in non-EU countries are often equal to or higher than those within the EU.
• High-quality clinical trials are being conducted in regions often perceived as developing countries.

Conclusions:

• ICH GCP Guidelines are effectively exportable and implementable globally.
• Clinical trials conducted outside the EU, including in Central/Eastern Europe and India, meet rigorous international quality standards.
• The perception of clinical trial quality in non-EU countries needs re-evaluation, as high standards are demonstrably achievable.